 | • レポートコード：QYR9NV05417 • 出版社/出版日：QYResearch / 2019年11月12日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、胃食道逆流症治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、制酸剤、H2受容体遮断薬、プロトンポンプ阻害剤（PPI）、運動促進薬、その他に、用途別には、病院薬局、ドラッグストア、雑貨店、スーパーマーケットにセグメント区分し、胃食道逆流症治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・胃食道逆流症治療薬の世界市場概要 ・胃食道逆流症治療薬の製造コスト構成分析 ・胃食道逆流症治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・胃食道逆流症治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・胃食道逆流症治療薬のセグメント分析（種類別） （制酸剤、H2受容体遮断薬、プロトンポンプ阻害剤（PPI）、運動促進薬、その他） ・胃食道逆流症治療薬のセグメント分析（用途別） （病院薬局、ドラッグストア、雑貨店、スーパーマーケット） ・胃食道逆流症治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （AstraZeneca、Eisai、Takeda Pharmaceutical、GlaxoSmithKline、Johnson & Johnson、Daewoong Pharmaceutical、Ironwood Pharmaceuticals、Rottapharm Madaus、Peer Medical、Reviva Pharmaceuticals、） ・胃食道逆流症治療薬の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Gastroesophageal Reflux Disease Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Gastroesophageal Reflux Disease Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gastroesophageal Reflux Disease Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Gastroesophageal Reflux Disease Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Gastroesophageal Reflux Disease Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
AstraZeneca
Eisai
Takeda Pharmaceutical
GlaxoSmithKline
Johnson & Johnson
Daewoong Pharmaceutical
Ironwood Pharmaceuticals
Rottapharm Madaus
Peer Medical
Reviva Pharmaceuticals
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Antacids
H2 Receptor Blockers
Proton Pump Inhibitors (PPIs)
Pro-kinetic Agents
Others
Segment by Application
Hospital Pharmacy
Drug Stores
General Stores
Supermarkets
Table of Contents
Executive Summary
1 Industry Overview of Gastroesophageal Reflux Disease Therapeutics
1.1 Definition of Gastroesophageal Reflux Disease Therapeutics
1.2 Gastroesophageal Reflux Disease Therapeutics Segment by Type
1.2.1 Global Gastroesophageal Reflux Disease Therapeutics Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Antacids
1.2.3 H2 Receptor Blockers
1.2.4 Proton Pump Inhibitors (PPIs)
1.2.5 Pro-kinetic Agents
1.2.6 Others
1.3 Gastroesophageal Reflux Disease Therapeutics Segment by Applications
1.3.1 Global Gastroesophageal Reflux Disease Therapeutics Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital Pharmacy
1.3.3 Drug Stores
1.3.4 General Stores
1.3.5 Supermarkets
1.4 Global Gastroesophageal Reflux Disease Therapeutics Overall Market
1.4.1 Global Gastroesophageal Reflux Disease Therapeutics Revenue (2014-2025)
1.4.2 Global Gastroesophageal Reflux Disease Therapeutics Production (2014-2025)
1.4.3 North America Gastroesophageal Reflux Disease Therapeutics Status and Prospect (2014-2025)
1.4.4 Europe Gastroesophageal Reflux Disease Therapeutics Status and Prospect (2014-2025)
1.4.5 China Gastroesophageal Reflux Disease Therapeutics Status and Prospect (2014-2025)
1.4.6 Japan Gastroesophageal Reflux Disease Therapeutics Status and Prospect (2014-2025)
1.4.7 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Status and Prospect (2014-2025)
1.4.8 India Gastroesophageal Reflux Disease Therapeutics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Gastroesophageal Reflux Disease Therapeutics
2.3 Manufacturing Process Analysis of Gastroesophageal Reflux Disease Therapeutics
2.4 Industry Chain Structure of Gastroesophageal Reflux Disease Therapeutics
3 Development and Manufacturing Plants Analysis of Gastroesophageal Reflux Disease Therapeutics
3.1 Capacity and Commercial Production Date
3.2 Global Gastroesophageal Reflux Disease Therapeutics Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Gastroesophageal Reflux Disease Therapeutics
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Gastroesophageal Reflux Disease Therapeutics Production and Capacity Analysis
4.2 Gastroesophageal Reflux Disease Therapeutics Revenue Analysis
4.3 Gastroesophageal Reflux Disease Therapeutics Price Analysis
4.4 Market Concentration Degree
5 Gastroesophageal Reflux Disease Therapeutics Regional Market Analysis
5.1 Gastroesophageal Reflux Disease Therapeutics Production by Regions
5.1.1 Global Gastroesophageal Reflux Disease Therapeutics Production by Regions
5.1.2 Global Gastroesophageal Reflux Disease Therapeutics Revenue by Regions
5.2 Gastroesophageal Reflux Disease Therapeutics Consumption by Regions
5.3 North America Gastroesophageal Reflux Disease Therapeutics Market Analysis
5.3.1 North America Gastroesophageal Reflux Disease Therapeutics Production
5.3.2 North America Gastroesophageal Reflux Disease Therapeutics Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Gastroesophageal Reflux Disease Therapeutics Import and Export
5.4 Europe Gastroesophageal Reflux Disease Therapeutics Market Analysis
5.4.1 Europe Gastroesophageal Reflux Disease Therapeutics Production
5.4.2 Europe Gastroesophageal Reflux Disease Therapeutics Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Gastroesophageal Reflux Disease Therapeutics Import and Export
5.5 China Gastroesophageal Reflux Disease Therapeutics Market Analysis
5.5.1 China Gastroesophageal Reflux Disease Therapeutics Production
5.5.2 China Gastroesophageal Reflux Disease Therapeutics Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Gastroesophageal Reflux Disease Therapeutics Import and Export
5.6 Japan Gastroesophageal Reflux Disease Therapeutics Market Analysis
5.6.1 Japan Gastroesophageal Reflux Disease Therapeutics Production
5.6.2 Japan Gastroesophageal Reflux Disease Therapeutics Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Gastroesophageal Reflux Disease Therapeutics Import and Export
5.7 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Analysis
5.7.1 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Production
5.7.2 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Import and Export
5.8 India Gastroesophageal Reflux Disease Therapeutics Market Analysis
5.8.1 India Gastroesophageal Reflux Disease Therapeutics Production
5.8.2 India Gastroesophageal Reflux Disease Therapeutics Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Gastroesophageal Reflux Disease Therapeutics Import and Export
6 Gastroesophageal Reflux Disease Therapeutics Segment Market Analysis (by Type)
6.1 Global Gastroesophageal Reflux Disease Therapeutics Production by Type
6.2 Global Gastroesophageal Reflux Disease Therapeutics Revenue by Type
6.3 Gastroesophageal Reflux Disease Therapeutics Price by Type
7 Gastroesophageal Reflux Disease Therapeutics Segment Market Analysis (by Application)
7.1 Global Gastroesophageal Reflux Disease Therapeutics Consumption by Application
7.2 Global Gastroesophageal Reflux Disease Therapeutics Consumption Market Share by Application (2014-2019)
8 Gastroesophageal Reflux Disease Therapeutics Major Manufacturers Analysis
8.1 AstraZeneca
8.1.1 AstraZeneca Gastroesophageal Reflux Disease Therapeutics Production Sites and Area Served
8.1.2 AstraZeneca Product Introduction, Application and Specification
8.1.3 AstraZeneca Gastroesophageal Reflux Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Eisai
8.2.1 Eisai Gastroesophageal Reflux Disease Therapeutics Production Sites and Area Served
8.2.2 Eisai Product Introduction, Application and Specification
8.2.3 Eisai Gastroesophageal Reflux Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Takeda Pharmaceutical
8.3.1 Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Production Sites and Area Served
8.3.2 Takeda Pharmaceutical Product Introduction, Application and Specification
8.3.3 Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 GlaxoSmithKline
8.4.1 GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Production Sites and Area Served
8.4.2 GlaxoSmithKline Product Introduction, Application and Specification
8.4.3 GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Johnson & Johnson
8.5.1 Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Production Sites and Area Served
8.5.2 Johnson & Johnson Product Introduction, Application and Specification
8.5.3 Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Daewoong Pharmaceutical
8.6.1 Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Production Sites and Area Served
8.6.2 Daewoong Pharmaceutical Product Introduction, Application and Specification
8.6.3 Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Ironwood Pharmaceuticals
8.7.1 Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Production Sites and Area Served
8.7.2 Ironwood Pharmaceuticals Product Introduction, Application and Specification
8.7.3 Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Rottapharm Madaus
8.8.1 Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Production Sites and Area Served
8.8.2 Rottapharm Madaus Product Introduction, Application and Specification
8.8.3 Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Peer Medical
8.9.1 Peer Medical Gastroesophageal Reflux Disease Therapeutics Production Sites and Area Served
8.9.2 Peer Medical Product Introduction, Application and Specification
8.9.3 Peer Medical Gastroesophageal Reflux Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Reviva Pharmaceuticals
8.10.1 Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Production Sites and Area Served
8.10.2 Reviva Pharmaceuticals Product Introduction, Application and Specification
8.10.3 Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Gastroesophageal Reflux Disease Therapeutics Market
9.1 Global Gastroesophageal Reflux Disease Therapeutics Market Trend Analysis
9.1.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size (Volume and Value) Forecast 2019-2025
9.2 Gastroesophageal Reflux Disease Therapeutics Regional Market Trend
9.2.1 North America Gastroesophageal Reflux Disease Therapeutics Forecast 2019-2025
9.2.2 Europe Gastroesophageal Reflux Disease Therapeutics Forecast 2019-2025
9.2.3 China Gastroesophageal Reflux Disease Therapeutics Forecast 2019-2025
9.2.4 Japan Gastroesophageal Reflux Disease Therapeutics Forecast 2019-2025
9.2.5 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Forecast 2019-2025
9.2.6 India Gastroesophageal Reflux Disease Therapeutics Forecast 2019-2025
9.3 Gastroesophageal Reflux Disease Therapeutics Market Trend (Product Type)
9.4 Gastroesophageal Reflux Disease Therapeutics Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Gastroesophageal Reflux Disease Therapeutics Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Gastroesophageal Reflux Disease Therapeutics
Table Global Gastroesophageal Reflux Disease Therapeutics Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Gastroesophageal Reflux Disease Therapeutics Production Market Share by Types in 2018
Figure Antacids Product Picture
Figure H2 Receptor Blockers Product Picture
Figure Proton Pump Inhibitors (PPIs) Product Picture
Figure Pro-kinetic Agents Product Picture
Figure Others Product Picture
Table Global Gastroesophageal Reflux Disease Therapeutics Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Gastroesophageal Reflux Disease Therapeutics Consumption Market Share by Applications in 2018
Figure Hospital Pharmacy
Figure Drug Stores
Figure General Stores
Figure Supermarkets
Figure Global Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2014-2025)
Figure Global Gastroesophageal Reflux Disease Therapeutics Production (K Pcs) (2014-2025)
Figure North America Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) (2014-2025)
Figure Europe Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) (2014-2025)
Figure China Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) (2014-2025)
Figure Japan Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) (2014-2025)
Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) (2014-2025)
Figure India Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) (2014-2025)
Table Gastroesophageal Reflux Disease Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Gastroesophageal Reflux Disease Therapeutics in 2018
Figure Manufacturing Process Analysis of Gastroesophageal Reflux Disease Therapeutics
Figure Industry Chain Structure of Gastroesophageal Reflux Disease Therapeutics
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Gastroesophageal Reflux Disease Therapeutics Manufacturing Plants Distribution
Table Gastroesophageal Reflux Disease Therapeutics Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Gastroesophageal Reflux Disease Therapeutics Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Gastroesophageal Reflux Disease Therapeutics Production (K Pcs) of Major Manufacturers (2014-2019)
Table Gastroesophageal Reflux Disease Therapeutics Production Market Share of Major Manufacturers (2014-2019)
Figure Gastroesophageal Reflux Disease Therapeutics Production Share by Manufacturers in 2018
Table Gastroesophageal Reflux Disease Therapeutics Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Gastroesophageal Reflux Disease Therapeutics Revenue Market Share of Major Manufacturers (2014-2019)
Figure Gastroesophageal Reflux Disease Therapeutics Revenue Share by Manufacturers in 2018
Table Gastroesophageal Reflux Disease Therapeutics Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Gastroesophageal Reflux Disease Therapeutics Production by Regions 2014-2019 (K Pcs)
Table Global Gastroesophageal Reflux Disease Therapeutics Production Market Share by Regions 2014-2019
Figure Global Gastroesophageal Reflux Disease Therapeutics Production Market Share by Regions in 2018
Table Global Gastroesophageal Reflux Disease Therapeutics Revenue by Regions 2014-2019 (Million USD)
Table Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Regions in 2018
Table Global Gastroesophageal Reflux Disease Therapeutics Consumption by Regions 2014-2019 (K Pcs)
Table Global Gastroesophageal Reflux Disease Therapeutics Consumption Market Share by Regions 2014-2019
Figure North America Gastroesophageal Reflux Disease Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure North America Gastroesophageal Reflux Disease Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table North America Gastroesophageal Reflux Disease Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Europe Gastroesophageal Reflux Disease Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Gastroesophageal Reflux Disease Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Gastroesophageal Reflux Disease Therapeutics Production, Consumption Import and Export (K Pcs)
Figure China Gastroesophageal Reflux Disease Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure China Gastroesophageal Reflux Disease Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table China Gastroesophageal Reflux Disease Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Japan Gastroesophageal Reflux Disease Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Gastroesophageal Reflux Disease Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Gastroesophageal Reflux Disease Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Gastroesophageal Reflux Disease Therapeutics Production, Consumption Import and Export (K Pcs)
Figure India Gastroesophageal Reflux Disease Therapeutics Production Growth Rate 2014-2019 (K Pcs)
Figure India Gastroesophageal Reflux Disease Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table India Gastroesophageal Reflux Disease Therapeutics Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Gastroesophageal Reflux Disease Therapeutics Market Share by Application (2014-2019)
Figure Global Value (Consumption) Gastroesophageal Reflux Disease Therapeutics Market Share by Application (2014-2019)
Table AstraZeneca Gastroesophageal Reflux Disease Therapeutics Production Sites and Area Served
Table AstraZeneca Gastroesophageal Reflux Disease Therapeutics Product Introduction, Application and Specification
Table AstraZeneca Gastroesophageal Reflux Disease Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AstraZeneca Gastroesophageal Reflux Disease Therapeutics Production Growth Rate (2014-2019)
Table AstraZeneca Gastroesophageal Reflux Disease Therapeutics Production Market Share (2014-2019)
Figure AstraZeneca Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (2014-2019)
Table AstraZeneca Gastroesophageal Reflux Disease Therapeutics Main Business and Markets Served
Table Eisai Gastroesophageal Reflux Disease Therapeutics Production Sites and Area Served
Table Eisai Gastroesophageal Reflux Disease Therapeutics Product Introduction, Application and Specification
Table Eisai Gastroesophageal Reflux Disease Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eisai Gastroesophageal Reflux Disease Therapeutics Production Growth Rate (2014-2019)
Table Eisai Gastroesophageal Reflux Disease Therapeutics Production Market Share (2014-2019)
Figure Eisai Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (2014-2019)
Table Eisai Gastroesophageal Reflux Disease Therapeutics Main Business and Markets Served
Table Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Production Sites and Area Served
Table Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Product Introduction, Application and Specification
Table Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Production Growth Rate (2014-2019)
Table Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Production Market Share (2014-2019)
Figure Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (2014-2019)
Table Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Main Business and Markets Served
Table GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Production Sites and Area Served
Table GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Product Introduction, Application and Specification
Table GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Production Growth Rate (2014-2019)
Table GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Production Market Share (2014-2019)
Figure GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (2014-2019)
Table GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Main Business and Markets Served
Table Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Production Sites and Area Served
Table Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Product Introduction, Application and Specification
Table Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Production Growth Rate (2014-2019)
Table Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Production Market Share (2014-2019)
Figure Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (2014-2019)
Table Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Main Business and Markets Served
Table Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Production Sites and Area Served
Table Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Product Introduction, Application and Specification
Table Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Production Growth Rate (2014-2019)
Table Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Production Market Share (2014-2019)
Figure Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (2014-2019)
Table Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Main Business and Markets Served
Table Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Production Sites and Area Served
Table Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Product Introduction, Application and Specification
Table Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Production Growth Rate (2014-2019)
Table Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Production Market Share (2014-2019)
Figure Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (2014-2019)
Table Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Main Business and Markets Served
Table Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Production Sites and Area Served
Table Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Product Introduction, Application and Specification
Table Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Production Growth Rate (2014-2019)
Table Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Production Market Share (2014-2019)
Figure Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (2014-2019)
Table Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Main Business and Markets Served
Table Peer Medical Gastroesophageal Reflux Disease Therapeutics Production Sites and Area Served
Table Peer Medical Gastroesophageal Reflux Disease Therapeutics Product Introduction, Application and Specification
Table Peer Medical Gastroesophageal Reflux Disease Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Peer Medical Gastroesophageal Reflux Disease Therapeutics Production Growth Rate (2014-2019)
Table Peer Medical Gastroesophageal Reflux Disease Therapeutics Production Market Share (2014-2019)
Figure Peer Medical Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (2014-2019)
Table Peer Medical Gastroesophageal Reflux Disease Therapeutics Main Business and Markets Served
Table Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Production Sites and Area Served
Table Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Product Introduction, Application and Specification
Table Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Production Growth Rate (2014-2019)
Table Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Production Market Share (2014-2019)
Figure Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (2014-2019)
Table Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Main Business and Markets Served
Figure Global Gastroesophageal Reflux Disease Therapeutics Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Gastroesophageal Reflux Disease Therapeutics Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Gastroesophageal Reflux Disease Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Gastroesophageal Reflux Disease Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Gastroesophageal Reflux Disease Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Gastroesophageal Reflux Disease Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Gastroesophageal Reflux Disease Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Gastroesophageal Reflux Disease Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Gastroesophageal Reflux Disease Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Gastroesophageal Reflux Disease Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Gastroesophageal Reflux Disease Therapeutics Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Gastroesophageal Reflux Disease Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Gastroesophageal Reflux Disease Therapeutics by Type (2019-2025)
Table Global Consumption (K Pcs) of Gastroesophageal Reflux Disease Therapeutics by Application (2019-2025)
Table Gastroesophageal Reflux Disease Therapeutics Distributors List
Table Gastroesophageal Reflux Disease Therapeutics Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
胃食道逆流症（GERD）薬のグローバル市場調査 2019年 The global Gastro Esophageal Reflux Disease (GERD) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Gastro Esophageal Reflux Disease (GERD) Drug volume and value at global level, regional level …- 世界及び中国の胃食道逆流疾患 (GERD) 治療薬市場2018 The 'Global and Chinese Gastro Esophageal Reflux Disease (GERD) Drug Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Gastro Esophageal Reflux Disease (GERD) Drug industry with a focus on the Chinese market. The report provides key s…
- 胃食道逆流症治療薬及び装置のグローバル市場調査 2019年 The global Gastro Esophageal Reflux Disease Drug and Devices market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Gastro Esophageal Reflux Disease Drug and Devices volume and value at global level, regio…
- 冠動脈疾患治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Coronary artery disease (CAD), also known as ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. Scope of the Report: This report studies the Coronary Artery Disease Therapeutics market status and…
- 網膜疾患治療薬のグローバル市場：規模・現状・予測2019-2025 Retinal diseases vary widely, but most of them cause visual symptoms. Retinal diseases can affect any part of your retina, a thin layer of tissue on the inside back wall of your eye.In 2018, the global Retinal Disease Therapeutics market size was xx million US$ and it is expected to reach xx million…